A description of perhaps the most important cancer company of the 21st century and my role in founding it.

1. Alpha Tau Medical, an Israeli company, found a way
for the first time to destroy all human tumors, using
Alpha Particles,without any side effects.
FROM GLOBES NEWSPAPER, THE WALL STREET JOURNAL OF ISRAEL
12.20.2016, 15:06 Gali Weinreb
"When I retired from managing Brainsway as CEO, I had no interest in entering a
new administrative postimmediately," says Uzi Sofer. "But one day, Howard
Sterling, investment banker, a man no one can refuse, called and told me he had a
mission for me," The mission Sofer received from Sterling was to save a company
called Althera Medical, an Israeli company headquartered in New York,
established on the basis of invention and research work of Prof. Yitzhak Kelson, an
eminent physics professor, and Prof. Yonah Kesari, an eminent biology professor
at Tel Aviv University. They have developed a new method to treat cancer using
the powerful radiation from alpha particles, the radioactive nuclei of helium, but
for various reasons the company, Althera, failed to take off.
Uzi Sofer did not come from Althera, but was most famous as CEO of Jerusalem’s
Brainsway the successfuldeveloper of a patented magnetic helmet for treatment of
depression and other neurological conditions. Sofer brought the idea of a super
helmet from a great Israeli scientific achievement to a marketed productapproved
all over the world. After the first phase of introducing the productto the United
States, Uzi Sofer felt exhausted its role, and the Board was looking for another
CEO. Todaythe company is traded on the Tel Aviv at a value of hundreds of
millions of shekels (worth actually fell after two years without Uzi).
Althera Medical just needed somebody, like Uzi who has taken a medical product
from conception, all the way, as he had done with Brainsway.

2. Althera Medical worked more than a decade trying to move from science t product
and regulatory approvals. But Althera had many mutual lawsuits over intellectual
property between Althera and Tel Aviv University. In addition, a series of internal
conflicts among the more than 70 shareholders and various debtholders led to a
halt the company's operations. In fact, from 2011, the company was paralyzed from
a business viewpoint. However, during this time the scientists ProfessorKelson
and ProfessorKesari continued to develop the technology of effective cancer
technology with no bad side effects in animals.
In 2014 the lawsuit over the patents with the University ended. The intellectual
property was taken over by Althera, and the University had partial ownership in
Althera and an Althera promise to royalties to the University. Althera Medical
could theoretically have continued to mature as to animal trials, but the
shareholders’ conflicts continued to simmer. Sofer said, "Howard told me - only
you can make peace between all these factors and you must to save perhaps
millions of people from dying of cancer."
Due to the commitment he felt for Sterling and the uniquely better cancer therapy,
Sofer decided to take on the task, at first unofficially and then officially. He began
to run between shareholders and debt holders and to speak to their hearts where he
showed them a simple message: if there is no agreement, there is nothing to fight
over. If they all agree, the technology would go forward and they could make a lot
of money. In the end, all the Althera stakeholders agreed to allow the transfer of
the intellectual property of Althera Medical new Israeli company, Alpha Tau
Medical. The agreement provided certain holdings in the new company for the
Althera shareholders and creditors. The transaction was closed in April 2016, and
Alpha Tau Medical became strongly operational under Sofer.
Marie Curie's radiation
Sofer said: "In 1898 Marie Curie discovered radium, a substanceemits alpha
particles radiation, and Curie, even then believed, that this radiation can aid in
cancer healing. Alpha Particles are ideal for the treatment of cancer. They are
heavy particles that hit the powerfully destroy tumor cells but do not pass into the

3. normal tissue surrounding the tumor or the systemic blood vessels in the rest of the
body. That is why there are no side effects.
Alpha particles can travel only about 1-2 microns, millions of a centimeter, in
tissue. This is advantageous because the damage it performs is very focused in one
place, only in the tumor. But this is also was a disadvantage, because it was clear,
to all scientists before ProfessorKelson did the impossible, that the alpha particles
could not travel far enough to move around and damage a whole cancer tumor.
Even if brought to the alpha particle radiation source very close to the tumor, the
alpha particles could hit only on the margins of the tumor, and not penetrate, kill,
the whole tumor.
ProfessorKelson had developed isotopes of Thorium, Radium and Radon which
disintegrate and emit energetic alpha particles with their strong radiation. Kelson
found a unique and patented way by making the emitting isotopes into
nanoparticles to get the isotope particles to move around the tumor. It is like the
recoil that moves a big rifle when a small bullet is energetically fired. Treatment of
tumors involves inserting isotope-energetically-emitting alpha particles in the
tumor, it is called intra-tumoral therapy. The number of isotopenano-particles
inserted in the tumor are in accordancewith the tumor size, type and location, so
that the fields of alpha particles’ radiation cover the entire tumor and lead to the
tumors complete destruction.
Treatment creates a uniform and extensive damage increase, but not the
surrounding tissue. No other cancer therapy, chemotherapy or radiation today is
known that does not have, usually severe, side effects.
The alpha particle medicine was tested in many different types of cancer, human
and others, in over 6,000 animals and it significantly contributed to the elimination
of a large variety of solid tumors, with minimal or no side effects. The productcan
be treated through repeated treatments or combined it with existing therapies,
including chemo and immune therapies.

4. Alpha Tau Medical decided not to concentrate on one cancer, and decided to look
at the experimental feasibility of treating various types of cancers in humans in
parallel (like Sofer did trials on many human neurological conditions at
Brainsway). In a Tel Aviv University physics building, Alpha Tau established a
unique super-clean) so no environmental impact) nuclear manufacturing laboratory
to producea sufficient quantity of alpha particle radiation sources for the several
human clinical trials. Human cancers where Alpha Tau is expected to be active in
the first phase are: head and neck cancer, skin cancer, prostate cancer, melanoma
of the eye, cervical cancer and rectal cancer. The studies are focused on patients
with cancer that conventional treatments are limited in their effectiveness (difficult
area to treat with external radiation, widespread metastases).
USA major clinical trial
One of the challenges of society in the future, if and when the Alpha Tau medicine
device is approved, will provide appropriate resources for growing specific and
individual patient treatment protocols, and taking into accountthe short shelf life
of the radioactive source. Sofer is confident that the challenges can be overcome
by, for example, putting the relatively small, relatively inexpensive, alpha particle
manufacturing facilities near major hospital centers all over the world.
Sofer "In April this year we did closing of transactions which compromised the
shareholders and debt holders and led to the establishment of Alpha Tau Medical.
Since then we have achieved many amazing and significant milestones, including
the establishment of the laboratory at the university and recruiting great
management and key-opinion-leader doctors. Apart from the scientists who
founded the company and me, we've enlisted Prof. Rafael Catane as medical
director, Amnon Gat, as head of marketing, and Dr. Morry Blomfeld, Meir
Jacobsonand of coursethe Howard Sterling as board members. Also we have
began patient recruitment in skin cancer and head and neck cancer at Beilinson
Medical center in Israel. We also received permission to begin a similar study in
Italy and we are working to obtain approvals for additional indications for further
studies in Germany and France. "

5. Writer believes that Alpha Medical buffalo will start in 2017 major clinical trial in
the United States,
‫את‬ ‫לרתום‬ ‫מנסים‬‫שנים‬ ‫"כבר‬ :‫סופר‬ * ‫הקרנות‬ ‫בטיפולי‬ ‫אלפא‬‫בחלקיקי‬ ‫שמשתמשת‬ ,‫מדיקל‬ ‫תאו‬
‫הדרך‬ ‫נמצאה‬ ‫עכשיו‬ ,‫בסרטן‬ ‫לטיפול‬ ‫האלפא‬ ‫"קרינת‬
20/12/2016, 15:06 ‫וינרב‬ ‫גלי‬
‫מניה‬‫"כשפרשתי‬ >> ‫למעקב‬‫נושאים‬‫ניהולי‬ ‫לתפקיד‬ ‫מיד‬ ‫להיכנס‬ ‫עניין‬ ‫לי‬ ‫היה‬ ‫לא‬,‫בריינסוויי‬ ‫ול‬
‫שאינני‬ ‫אדם‬ ,‫סטרלינג‬ ‫הווארד‬ ‫ההשקעות‬ ‫בנקאי‬ ‫אלי‬‫התקשר‬ ‫אחד‬ ‫יום‬ ‫"אך‬ .‫סופר‬ ‫עוזי‬ ‫מספר‬,"‫חדש‬
‫להציל‬‫היתה‬ ‫מסטרלינג‬ ‫סופר‬ ‫שקיבל‬ ‫בשבילי".המשימה‬ ‫משימה‬ ‫לו‬‫שיש‬ ‫לי‬ ‫אמר‬ ‫והוא‬ ,‫לו‬ ‫לסרב‬ ‫יכול‬
‫שהוקמה‬ ,‫מדיקל‬‫אלת'רה‬‫בשם‬ ‫חברה‬'‫ופרופ‬ ‫קלזון‬ ‫יצחק‬ '‫פרופ‬ ‫של‬ ‫המחקר‬ ‫ועבודת‬‫המצאתם‬ ‫בסיס‬ ‫על‬
‫קרינת‬ ‫באמצעות‬ ,‫בסרטן‬ ‫לטיפול‬‫חדשה‬ ‫שיטה‬ ‫פיתחו‬‫השניים‬ .‫אביב‬ ‫תל‬ ‫מאוניברסיטת‬ ‫קיסרי‬ ‫יונה‬
‫להמריא‬‫הצליחה‬ ‫לא‬ ‫החברה‬ ‫שונות‬ ‫מסיבות‬ ‫אולם‬ ,‫אלפא‬ ‫.חלקיקי‬
‫המפתח‬ ,‫בריינסוויי‬ ‫כמנכ"ל‬ ‫אולם‬ ,‫במקור‬ ‫הביומד‬ ‫מתחום‬ ‫הגיע‬ ‫לא‬ ‫סופר‬‫לטיפול‬‫מגנטית‬ ‫קסדה‬ ‫ת‬
‫שיפוי‬ ‫בעל‬ ,‫בארה"ב‬ ‫המשווק‬ ‫מאושר‬ ‫למוצר‬ ‫ועד‬ ‫מדעי‬ ‫מרעיון‬ ‫הקסדה‬ ‫את‬ ‫סופר‬ ‫הביא‬ ,‫בדיכאון‬
‫לארה"ב‬ ‫המוצר‬ ‫החדרת‬ ‫של‬ ‫הראשון‬ ‫השלב‬ ‫לאחר‬.‫העולם‬ ‫ברחבי‬ ‫רבים‬ ‫רגולטוריים‬ ‫ואישורים‬ ‫ביטוחי‬
‫ה‬ ‫היום‬ .‫אחר‬ ‫מנכ"ל‬ ‫חיפש‬ ‫החברה‬ ‫דירקטוריון‬ ‫וגם‬,‫תפקידו‬ ‫את‬ ‫מיצה‬ ‫כי‬ ‫סופר‬ ‫חש‬‫נסחרת‬ ‫חברה‬
‫בשנתיים‬ ‫צנח‬ ‫דווקא‬ ‫ששווייה‬ ‫(לאחר‬‫שקלים‬ ‫מיליוני‬ ‫מאות‬ ‫של‬ ‫שווי‬ ‫לפי‬ ‫אביב‬ ‫בתל‬ ‫בבורסה‬
‫.)האחרונות‬
‫הדרך‬ ‫כל‬ ‫את‬ ‫עשה‬ ‫שכבר‬ ‫למישהו‬ ‫בדיוק‬ ‫זקוקה‬ ‫היתה‬ ‫מדיקל‬‫.אלת'רה‬
‫של‬ ‫למסכת‬ ‫נכנסו‬ ‫הם‬ ‫אך‬,‫שלה‬ ‫המוצר‬ ‫את‬ ‫לקדם‬ ‫בניסיון‬ ‫מעשור‬ ‫יותר‬ ‫פעלה‬ ‫מדיקל‬‫"אלת'רה‬ :‫סופר‬
‫משפט‬‫תביעות‬‫סכסוכים‬ ‫של‬ ‫שורה‬ ,‫לכך‬‫בנוסף‬ .‫האוניברסיטה‬ ‫לבין‬ ‫בינם‬ ‫הרוחני‬ ‫הקניין‬ ‫על‬ ‫הדדיות‬ ‫יות‬
‫מ‬ ‫יותר‬ ‫בין‬ ‫פנימיים‬-07.‫החברה‬ ‫של‬ ‫הפעילות‬ ‫להפסקת‬ ‫הביאו‬ ‫השונים‬ ‫החוב‬ ‫ובעלי‬‫המניות‬ ‫בעלי‬
‫מ‬‫למעשה‬-1722‫קיסרי‬ '‫ופרופ‬ ‫קלזון‬ '‫פרופ‬‫המדענים‬ ‫הזה‬ ‫הזמן‬ ‫כל‬‫במהלך‬ .‫משותקת‬ ‫היתה‬ ‫החברה‬
‫לפתח‬ ‫המשיכו‬‫הטכנולוגיה‬ ‫את‬ ".
‫ב‬-1722‫חלקית‬ ‫בעלות‬ ‫קיבלה‬ ‫והאוניברסיטה‬‫החברה‬ ‫לידי‬‫עבר‬ ‫הרוחני‬ ‫הקניין‬ ,‫המשפט‬ ‫הסתיים‬
‫הגיעו‬ ‫כבר‬ ‫אז‬ ‫עד‬ ‫אבל‬,‫בשלה‬ ‫להמשיך‬‫תיאורטית‬ ‫יכלה‬ ‫אלת'רה‬ .‫לתמלוגים‬ ‫והבטחה‬‫בחברה‬

6. ‫לי‬ ‫אמר‬ ‫"האוורד‬ .‫רתיחה‬ ‫לכדי‬ ‫המניות‬ ‫בעלי‬ ‫בין‬ ‫הסכסוכים‬-‫בין‬ ‫שלום‬ ‫לעשות‬ ‫יכול‬ ‫אתה‬ ‫רק‬‫כל‬
‫סופר‬ ‫אומר‬ ,"‫הללו‬ ‫.הגורמים‬
‫על‬ ‫לקחת‬ ‫סופר‬ ‫החליט‬ ,‫בטכנולוגיה‬ ‫שמצא‬ ‫הרב‬ ‫העניין‬ ‫ובשל‬ ‫סטרלינג‬ ‫כלפי‬ ‫שחש‬ ‫המחויבות‬ ‫בשל‬
‫בעלי‬ ‫בין‬ ‫להתרוצץ‬ ‫החל‬ ‫הוא‬ .‫רשמי‬ ‫באופן‬ ‫ובהמשך‬ ‫רשמי‬ ‫לא‬ ‫באופן‬ ‫תחילה‬ ,‫המשימה‬ ‫את‬ ‫עצמו‬
‫ח‬ ‫תהיה‬ ‫לא‬ ‫אם‬ :‫פשוט‬ ‫מסר‬ ‫להם‬ ‫מציג‬ ‫כשהוא‬,‫לבם‬ ‫אל‬ ‫ולדבר‬ ‫והחוב‬ ‫המניות‬.‫לריב‬ ‫מה‬ ‫על‬ ‫אין‬ ,‫ברה‬
‫אלפא‬,‫חדשה‬ ‫לחברה‬‫אלת'רה‬ ‫של‬ ‫הרוחני‬ ‫הקניין‬ ‫את‬‫להעביר‬ ‫שיאפשר‬ ‫המודל‬ ‫נמצא‬ ‫דבר‬ ‫של‬ ‫בסופו‬
‫החברה‬ ‫של‬ ‫החוב‬ ‫ולבעלי‬ ‫ההון‬ ‫לבעלי‬‫החדשה‬ ‫בחברה‬ ‫מסוימות‬ ‫אחזקות‬ ‫ולהעניק‬ ,‫מדיקל‬ ‫תאו‬
‫באפריל‬ ‫נסגרה‬ ‫העסקה‬ .‫הוותיקה‬1722‫לדרך‬‫רשמית‬ ‫יצאה‬ ‫מדיקל‬ ‫תאו‬ ‫ואלפא‬ , .
‫הקרינה‬‫קירי‬ ‫מארי‬ ‫של‬
‫"ב‬ :‫סופר‬-2181‫שהקרינה‬ ‫האמינה‬ ‫אז‬ ‫וכבר‬ ,‫אלפא‬‫קרינת‬ ‫פולט‬ ‫חומר‬ ,‫הרדיום‬ ‫את‬ ‫קירי‬ ‫מארי‬ ‫גילתה‬
‫אידיאליים‬ ‫מסוימות‬‫מבחינות‬ ‫הם‬ ‫האלפא‬ ‫קרינת‬ ‫את‬ ‫המרכיבים‬ ‫החלקיקים‬ .‫בריפוי‬ ‫לסייע‬ ‫יכולה‬ ‫הזו‬
‫ל‬‫שנמצאת‬ ‫ברקמה‬ ‫עוצמתית‬ ‫בצורה‬ ‫פוגעים‬ ‫אשר‬ ‫כבדים‬ ‫חלקיקים‬ ‫הם‬ .‫בסרטן‬ ‫לטיפול‬‫לא‬ ‫אך‬,‫ידם‬
‫הבאות‬ ‫לרקמות‬ ‫הלאה‬ ‫."עוברים‬
‫כ‬ ‫רק‬ ‫לנוע‬ ‫יכול‬ ‫אלפא‬ ‫חלקיק‬-2/17‫הוא‬ ‫מבצע‬ ‫שהוא‬ ‫שהנזק‬ ‫משום‬ ,‫יתרון‬ ‫זה‬ .‫הרקמה‬ ‫בתוך‬ ‫מילימטר‬
‫במרכז‬ ‫שנמצא‬ ‫גידול‬ ‫על‬ ‫להקרין‬ ‫אפשר‬ ‫אי‬‫שכך‬ ‫ברור‬ ‫כי‬ ,‫חיסרון‬ ‫גם‬ ‫זהו‬ ‫אך‬ .‫אחד‬ ‫במקום‬ ‫מאוד‬ ‫ממוקד‬
‫הגוף‬-‫לפני‬ ‫עוד‬ ‫לאיבוד‬‫תלך‬ ‫הקרינה‬ ‫כל‬ ‫שכן‬‫הקרינה‬ ‫מקור‬ ‫יובא‬ ‫אם‬ ‫גם‬.‫העור‬ ‫את‬ ‫אפילו‬ ‫שתחדור‬
‫לעומקו‬ ‫יחדור‬ ‫ולא‬ ,‫הגידול‬ ‫בשולי‬ ‫ורק‬ ‫אך‬ ‫יפגע‬ ‫הוא‬ ,‫לגידול‬ ‫מאוד‬ ‫.קרוב‬
‫אלו‬ ‫אטומים‬ .‫אלפא‬ ‫פולטי‬ ‫לאטומים‬ ‫מתפרק‬ ‫אשר‬ ‫איזוטופ‬ ‫המכיל‬ ‫מקור‬‫פיתחה‬ ‫מדיקל‬ ‫תאו‬ ‫אלפא‬
‫פולטים‬‫שהם‬ ‫לפני‬‫מילימטרים‬ ‫כמה‬ ‫של‬ ‫למרחק‬ ‫הגידול‬ ‫בתוך‬ ‫לנוע‬ ‫יכולים‬‫העוצמתי‬ ‫האלפא‬ ‫חלקיק‬ ‫את‬
‫החברה‬ ‫של‬ ‫הטיפול‬ .‫מהמקור‬‫משמעותי‬ ‫במרחק‬ ‫אלפא‬‫קרינת‬ ‫שדה‬ ‫נוצר‬ ‫זו‬‫בצורה‬ .)‫הטווח‬ ‫קצר‬ ‫(אך‬
‫האלפא‬ ‫קרינת‬ ‫ששדות‬ ‫כך‬ ,‫ולסוגו‬ ‫למיקומו‬ ,‫הגידול‬ ‫לגודל‬‫בהתאם‬ ‫עצמו‬ ‫לגידול‬ ‫מקורות‬‫בהחדרת‬ ‫כרוך‬
‫להשמדתו‬ ‫ויביאו‬ ‫הגידול‬ ‫שטח‬ ‫כל‬ ‫את‬ ‫יכסו‬ ‫המקורות‬ ‫.של‬
‫יוצר‬ ‫הטיפול‬‫לוואי‬‫תופעות‬ ‫שום‬ ‫אין‬ ‫לטיפול‬ .‫אותו‬‫הסובבות‬ ‫לרקמות‬ ‫לא‬ ‫אך‬ ,‫לגידול‬ ‫ונרחב‬ ‫אחיד‬ ‫נזק‬
‫היום‬ ‫הנפוצים‬ ‫סרטן‬ ‫נגד‬ ‫ההקרנה‬ ‫טיפולי‬ ‫עם‬ ‫המזוהות‬ )‫הגוף‬ ‫כל‬ ‫(של‬ ‫.סיסטמיות‬

7. ‫כ‬ ‫על‬ ‫סרטן‬ ‫של‬ ‫שונים‬ ‫בסוגים‬ ‫נבדק‬ ‫המוצר‬-2,777‫לחיסול‬ ‫משמעותי‬ ‫באופן‬ ‫כתורם‬ ‫ונמצא‬ ,‫חיים‬ ‫בעלי‬
‫של‬ ‫גדול‬ ‫מגוון‬‫בטיפולים‬ ‫המוצר‬ ‫באמצעות‬ ‫לטפל‬‫ניתן‬ .‫לוואי‬ ‫תופעות‬ ‫במינימום‬ ,‫מוצקים‬ ‫גידולים‬
‫קיים‬ ‫טיפול‬ ‫כל‬ ‫עם‬ ‫אותו‬ ‫לשלב‬ ‫או‬‫ונשנים‬ ‫.חוזרים‬
‫במקביל‬ ‫היתכנות‬ ‫הוכחת‬ ‫ניסויי‬ ‫לכמה‬ ‫לצאת‬ ‫והחליטה‬ ,‫להתרכז‬ ‫סרטן‬ ‫סוגי‬ ‫באילו‬ ‫התלבטה‬ ‫החברה‬
‫א‬ ‫תל‬ ‫אוניברסיטת‬‫בתוך‬ .)‫בבריינסוויי‬ ‫סופר‬ ‫של‬ ‫לגישה‬ ‫(בדומה‬‫גרעינית‬‫מעבדה‬ ‫תאו‬ ‫אלפא‬ ‫הקימה‬ ‫ביב‬
‫התחומים‬ .‫קליניים‬ ‫ניסויים‬ ‫למספר‬ ‫המספיקה‬ ‫בכמות‬ ‫הקרינה‬ ‫מקורות‬ ‫את‬ ‫לייצר‬ ‫לה‬‫המאפשרת‬ ‫ייחודית‬
‫סרטן‬ ,‫העור‬ ‫סרטן‬ ,‫והצוואר‬‫הראש‬ ‫סרטן‬ :‫הם‬ ‫הראשון‬ ‫בשלב‬ ‫פעילה‬ ‫להיות‬ ‫צפויה‬ ‫היא‬ ‫שבהם‬
‫המ‬ .‫הרקטום‬ ‫וסרטן‬‫הרחם‬ ‫צוואר‬ ‫סרטן‬ ,‫העין‬ ‫של‬ ‫מלנומה‬,‫הערמונית‬‫אשר‬ ‫סרטן‬ ‫בחולי‬ ‫יתמקדו‬ ‫חקרים‬
‫גרורות‬,‫חיצונית‬ ‫והקרנה‬‫לניתוח‬ ‫הקשה‬ ‫(אזור‬‫ביעילותן‬ ‫מוגבלות‬‫המקובלות‬ ‫הטיפול‬ ‫אפשרויות‬
‫.)מפושטות‬
‫בארה"ב‬ ‫משמעותי‬ ‫קליני‬ ‫ניסוי‬
‫ספציפית‬ ‫המתאימים‬ ‫מקורות‬ ‫לספק‬ ‫יהיה‬ ,‫המוצר‬ ‫יאושר‬ ‫וכאשר‬ ‫אם‬,‫בעתיד‬ ‫החברה‬ ‫של‬ ‫האתגרים‬ ‫אחד‬
‫טיפו‬ ‫ולפרוטוקול‬ ‫לגידול‬‫אולם‬ .‫המקור‬ ‫של‬ ‫הקצרים‬ ‫המדף‬ ‫בחיי‬ ‫התחשבות‬ ‫תוך‬ ‫וזאת‬,‫מסוים‬ ‫בחולה‬ ‫ל‬
‫עבורה‬ ‫בידול‬ ‫נקודת‬ ‫גם‬ ‫להיות‬ ‫תוכל‬ ,‫אותה‬ ‫לפתח‬ ‫תצליח‬ ‫החברה‬ ‫אם‬ ,‫הזו‬ ‫.היכולת‬
‫תאו‬ ‫אלפא‬ ‫והקמת‬ ‫המניות‬ ‫בעלי‬ ‫בין‬ ‫הפשרה‬ ‫עסקת‬ ‫של‬ ‫הקלוזינג‬ ‫את‬ ‫עשינו‬ ‫השנה‬ ‫"באפריל‬ :‫סופר‬
‫כול‬,‫מדהימות‬ ‫דרך‬ ‫אבני‬ ‫השגנו‬ ‫מאז‬ .‫מדיקל‬‫חוץ‬ .‫אדם‬ ‫כוח‬ ‫וגיוס‬‫באוניברסיטה‬ ‫המעבדה‬ ‫הקמת‬ ‫ל‬
‫גת‬ ‫אמנון‬ ‫את‬ ,‫רפואי‬ ‫כמנהל‬ ‫קטן‬ ‫רפי‬ '‫פרופ‬ ‫את‬ ‫גם‬ ‫גייסנו‬ ‫ואותי‬‫החברה‬ ‫את‬ ‫שיסדו‬ ‫מהמדענים‬
.‫דירקטוריון‬ ‫כחברי‬ ‫סטרלינג‬ ‫הווארד‬ ‫את‬ ‫וכמובן‬ ‫יעקובסון‬ ‫מאיר‬,‫בלונפלד‬ ‫מורי‬ ‫ואת‬ ,‫כללי‬ ‫כסמנכ"ל‬
‫הע‬ ‫בסרטן‬ ‫לניסוי‬ ‫חולים‬ ‫בגיוס‬ ‫החלנו‬ ‫כן‬ ‫כמו‬‫בניסוי‬ ‫להתחיל‬ ‫אישור‬ ‫קיבלנו‬ ,‫בבילינסון‬ ‫צוואר‬ ‫וראש‬ ‫ור‬
‫בגרמניה‬ ‫נוספות‬ ‫באינדיקציות‬ ‫נוספים‬ ‫למחקרים‬‫אישורים‬ ‫לקבלת‬ ‫פועלים‬ ‫ואנו‬‫באיטליה‬ ‫דומה‬
‫."ובצרפת‬